Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese

Breadcrumb

  1. Home
  2. Microbiota 17 - December 2022
  3. Gut Microbiota #17
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Microbiota 17 - December 2022
  3. Gut Microbiota #17
Gastroenterology

Gut Microbiota #17

Dysbiosis
Gastroenterology

By Pr. Satu Pekkala
Academy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of Jyväskylä, Finland

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

Microbiota mag 17_bandeau press gut

About this article

Created 17 January 2023
Updated 14 March 2024

LINKING GASTROINTESTINAL MICROBIOTA AND METABOLOME DYNAMICS TO CLINICAL OUTCOMES IN PAEDIATRIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

Vaitkute G, Panic G, Alber DG, et al. Linking gastrointestinal microbiota and metabolome dynamics to clinical outcomes in paediatric haematopoietic stem cell transplantation. Microbiome 2022; 10: 89.

Haematopoietic stem cell transplantation (HSCT) is used to treat many pathological conditions. At post-HSCT graft-versushost disease and infections can develop, being major causes of mortality. The current understanding of the role of the gut microbiota (GM) on adverse outcomes in paediatric patients post-HSCT is scarce. In a longitudinal study, Vaitkute et al. determined whether the GM and fecal metabolome associates with the clinical outcomes in 64 paediatric HSCT patients during ~ 66-days inpatient stay. Following HSCT, the GM alpha-diversity decreased. There were compositional shifts in the GM, and most of the patients did not return to their initial GM composition. The GM was clustered into community state types [CST(s)]. CST1 was common before HSCT, and included abundant Clostridium XIVa, Bacteroides and Lachnospiraceae. The lack of total parenteral nutrition contributed to CST1. CST2 was common at post-HSCT and was characterized by abundant Streptococcus and Staphylococcus as well as the use of vancomycin and metronidazole. CST3 was also common at post-HSCT and included abundant Enterococcus, Enterobacteriaceae and Escherichia. CST3 associated with a higher risk of viraemia, total parenteral nutrition and various antimicrobials. The metabolomic analyses revealed that fecal butyrate at baseline associated with a lower risk of viraemia. Longitudinally, acetate and butyrate decreased, and glucose increased after HSCT. The identified GM taxa and metabolites may be useful biomarkers for predicting the risk of complications post-HSCT. However, larger longitudinal studies are warranted.

A PROSPECTIVE STUDY OF THE INFANT GUT MICROBIOME IN RELATION TO VACCINE RESPONSE

Moroishi Y, Gui J, Nadeau KC, et al. A prospective study of the infant gut microbiome in relation to vaccine response. Pediatr Res 2022 [Epub ahead of print].

The establishment of infant gut microbiota (GM) early in life is essential for the developing immune system. In addition, GM contributes to immune responses to vaccination, such as polio vaccine. However, research in this field is still scarce. Moroishi et al. enrolled 83 infants and studied the composition and functions of the early-life (6-weeks of age) GM in relation to infant antibody response to pneumococcal capsular polysaccharide (PCP) and tetanus toxoid (TT) at 1-year of age. PERMANOVA analyses of pair-wise GM community composition showed a weak association with PCP and TT antibody responses. In metagenome analyses, the authors found a negative association between TT response and Aeriscardovia aeriphila, whereas the association was positive with Staphylococcus aureus, Escherichia coli, Streptococcus thermophilus, and Anaerococcus vaginalis. However, only A. aeriphila remained significant after FDR correction. Lower PCP vaccine response associated with nine pathways, such as phenylalanine biosynthesis and pyrimidine deoxyribonucleotides de novo biosynthesis. In contrast, pantothenate and coenzyme A biosynthesis III, pyrimidine ribonucleosides degradation, methylphosphonate degradation II, and pyrimidine ribonucleotides de novo biosynthesis pathways were associated with higher PCP response. Five pathways associated positively with TT response, including especially CDP-diacylglycerol biosynthesis I and CDP-diacylglycerol. As a conclusion of this study, A. aeriphila could be used as a biomarker of TT response. Further, the early-life GM functions may influence an infant’s vaccine response.

META-ANALYSIS OF MUCOSAL MICROBIOTA REVEALS UNIVERSAL MICROBIAL SIGNATURES AND DYSBIOSIS IN GASTRIC CARCINOGENESIS

Liu C, Ng SK, Ding Y, et al. Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis. Oncogene 2022; 41: 3599-10.

Gastric cancer (GC) is the 4th leading cause of cancer death. The developmental stages of GC are superficial gastritis (SG), atrophic gastritis (AG), intestinal metaplasia (IM), dysplasia and gastric carcinoma. Helicobacter pylori infection is a common player in GC that reduces secretion of stomach acid, allowing overgrowth of non-H. pylori microbes. Studies on the associations between gastric microbiota and GC have been inconsistent. Liu et al. did a meta-analysis of gastric microbiota from six independent studies to identify microbial signatures in GC. Alpha-diversity was lower in GC than in SG, AG and IM. Veillonella, Dialister, Granulicatella, Herbaspirillum, Comamonas, Chryseobacterium, Shewanella and Helicobacter were newly identified in this study as universal biomarkers discriminating GC from SG. In addition, opportunistic pathobionts Fusobacterium, Parvimonas, Veillonella, Prevotella and Peptostreptococcus were more abundant in GC than in SG. Contrarily, the abundance of Bifidobacterium, Bacillus and Blautia were lower. The microbial functions were inferred using PICRUSt2. Compared to SG, the most enriched pathway in GC was peptidoglycan maturation of peptidoglycan biosynthesis. The most depleted pathway in GC was Helicobacter specific tricarboxylic acid cycle, which agrees with the very low abundance of Helicobacter in GC patients. The authors further found that Helicobacter seems to affect gastric microbiota as H. pylori-negative patients had higher microbial diversity than the H. pylori-positive. To conclude, gastric microbiome can be a biomarker capable of distinguishing patients across disease stages.

Tags
Vaccination Gut microbiota Microbiome Flora
    Focus
    Microbiota 17 - December 2022
    • Overview
      • Microbial colonization as a determinant factor for health during the first 1000 days of life
    • Commented article
      • Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signalling in mice
      • Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants
    • Focus on
      • The Gut-Brain axis
    • Congress review
      • Highlights from the UEGW
    • Press review
      • Gut Microbiota #17
      • Skin Microbiota #17
    • Expert opinion
      • Impact of beer and non alcoholic beer consumption on the gut microbiota
    Created 17 January 2023
    Updated 14 March 2024

    About this article

    To know more about this topic.

    Main topic

    Dysbiosis

    Medical practice

    Gastroenterology

    Content type

    Press review
    Highlights from the UEGW
    Skin Microbiota #17
    Focus

    Microbiota 17 - December 2022

    Overview

    Microbial colonization as a determinant factor for health during the first 1000 days of life

    Commented article

    Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signalling in mice Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

    Focus on

    The Gut-Brain axis

    Congress review

    Highlights from the UEGW

    Press review

    Gut Microbiota #17 Skin Microbiota #17

    Expert opinion

    Impact of beer and non alcoholic beer consumption on the gut microbiota

    Continue reading

    News
    24.01.2024

    Effect of gut microbiota on Covid vaccination, and vice-versa

    Read the article
    16.12.2022

    Does the gut microbiota influence vaccine efficacy?

    Read the article
    19.07.2024

    Key take aways on diarrhea

    Read the article

    Microbiota and Infection Diarrhea: virtuous or vicious circle ?

    Find out more
    Actu PRO : Vaccination post-antibiothérapie : effet sur l’immunité, rôle du microbiote
    06.01.2020

    Vaccination after antibiotic therapy: effect on immunity and role of the microbiota

    Read the article

    Gut Microbiota #18

    By Pr. Satu Pekkala Academy of Finland Research Fellow, Faculty of Sport and Health Sciences, Univers...

    Find out more

    Targeting the gut microbiota to optimize vaccine efficacy?

    by Dr Genelle Healey

    Find out more
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo